Neutrophils as key regulators of tumor microenvironment in breast cancer: a focus on N1 and N2 polarization
- PMID: 40486595
- PMCID: PMC12140695
- DOI: 10.1097/MS9.0000000000003269
Neutrophils as key regulators of tumor microenvironment in breast cancer: a focus on N1 and N2 polarization
Abstract
Neutrophils, the most abundant type of white blood cells in the human body, play a vital role in the immune response against infections and tissue injury. However, in the context of cancer, their function becomes more complex and context-dependent. In breast cancer, neutrophils are key players in shaping the tumor microenvironment (TME), a highly dynamic ecosystem where various cell types, extracellular matrix components, and soluble factors interact to influence tumor progression, immune evasion, and metastasis. Neutrophils in the TME are not just passive participants but actively engage in altering tumor biology, either supporting or inhibiting tumor growth depending on their polarization status. Neutrophils exhibit plasticity in their phenotype and function, which can be categorized into two polarized forms: N1 and N2. N1 neutrophils are associated with antitumor responses, promoting immune activation, direct cytotoxicity against tumor cells, and facilitating the clearance of cancerous cells through the release of reactive oxygen species, cytokines, and chemokines. Conversely, N2 neutrophils contribute to tumor progression by fostering an immunosuppressive environment, promoting angiogenesis, enhancing tumor cell migration and invasion, and aiding in the establishment of metastatic niches. This dichotomy of neutrophil polarization plays a crucial role in determining breast cancer progression, metastasis, and response to treatment.
Keywords: N1 polarization; N2 polarization; breast cancer; neutrophils; tumor microenvironment.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. The author declares no conflict of interest.
Figures
Similar articles
-
The balance between N1 and N2 neutrophils implications for breast cancer immunotherapy: a narrative review.Ann Med Surg (Lond). 2025 May 12;87(6):3682-3690. doi: 10.1097/MS9.0000000000003361. eCollection 2025 Jun. Ann Med Surg (Lond). 2025. PMID: 40486616 Free PMC article. Review.
-
Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma.Hum Cell. 2024 May;37(3):714-728. doi: 10.1007/s13577-024-01024-7. Epub 2024 Feb 15. Hum Cell. 2024. PMID: 38358636
-
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy.Cancers (Basel). 2025 Apr 5;17(7):1232. doi: 10.3390/cancers17071232. Cancers (Basel). 2025. PMID: 40227814 Free PMC article. Review.
-
Neutrophils as active regulators of the immune system in the tumor microenvironment.J Leukoc Biol. 2017 Aug;102(2):343-349. doi: 10.1189/jlb.5MR1216-508R. Epub 2017 Mar 6. J Leukoc Biol. 2017. PMID: 28264904 Review.
-
The heterogeneous roles of neutrophils in gastric cancer: scaffold or target?Cell Mol Biol Lett. 2025 Jun 16;30(1):71. doi: 10.1186/s11658-025-00744-4. Cell Mol Biol Lett. 2025. PMID: 40524157 Free PMC article. Review.
Cited by
-
N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications.Breast Cancer (Dove Med Press). 2025 Jul 23;17:639-651. doi: 10.2147/BCTT.S542787. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 40718361 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources